BioSpace News Archive

Aurinia Pharmaceuticals Inc. announced data from the kidney biopsy sub-study of the AURORA clinical trial program was presented at the Congress of Clinical Rheumatology East Conference May 4 – 7, 2023.

IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the first quarter ended March 31, 2023.

Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products , today announced that Murray S. Kessler has notified the Company of his intent to retire as President and Chief Executive Officer, with a target effective date of July 31, 2023.

Immunic, Inc. announced that the company will release its financial results for the first quarter ended March 31, 2023, including a corporate update, on Thursday, May 11, 2023, before the opening of the U.S. financial markets.

ImmunoGen, Inc. announced that results from the Phase 3 confirmatory MIRASOL trial evaluating the safety and efficacy of ELAHERE® compared to chemotherapy in patients with folate receptor alpha -positive platinum-resistant ovarian cancer, have been selected for a late-breaking oral presentation at the 2023 American Society of Clinical Oncology Annual Meeting taking place June 2-6, 2023 in Chicago, Illinois.

Voyager Therapeutics, Inc., a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, announced the appointment of George Scangos, Ph.D., to its Board of Directors.

Eagle Pharmaceuticals, Inc. announced financial results for the three months ended March 31, 2023.

Waters Corporation announced its financial results for the first quarter of 2023.

Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system disorders, announced that senior members of its Management Team will present at BioEquity Europe taking place May 14-16, 2023, in Dublin, Ireland.

TELA Bio, Inc., a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, will sponsor a Women in Surgery Dinner on May 10, 2023, at the International Hernia Collaboration Conference in Rio de Janeiro, Brazil.